Policy & Advocacy

ASGCT Holds First Joint Meeting With Brazilian Association

ASGCT Staff - December 03, 2020

Speakers addressed the scientific and infrastructural requirements for successful translation into clinical research for oncology, hemophilia, and sickle cell disease.

ASGCT held its first ever collaborative event with the Brazilian Association of Cellular and Gene Therapy (ABTCel-Gen) virtually Dec. 2. Academic researchers from Brazil and the U.S. shared their experiences in establishing clinical trials for gene therapies to assist in advancing further development within Brazil. The ASGCT Global Outreach Committee co-hosted this program as part of its objective to encourage clinical development in middle-income countries that have burgeoning regulatory frameworks and medical systems that can support gene therapy. By facilitating the development and approval of more therapies globally, such events contribute to the Society’s strategic goal to foster equitable access to gene and cell therapies in low- and middle-income countries.

Speakers addressed the scientific and infrastructural requirements for successful translation into clinical research for oncology, hemophilia, and sickle cell disease. In addition, ASGCT Board Member Maritza McIntyre, Ph.D., provided recommendations on information to include in an IND application and ways to overcome common regulatory challenges in gene therapy trials. A recording of the program is available below. The Society will continue to partner with ABTCel-Gen when ASGCT members speak on gene editing at ABTCel-Gen’s virtual annual meeting in April.

Share This Page

Related Articles

Policy & Advocacy

FDA Approves First CAR T-Cell Therapy for ALL

ASGCT Staff - October 14, 2021
Policy & Advocacy

ASGCT Gears Up for 2021 Policy Progress

Francesca Cook, MPH - January 12, 2021
Policy & Advocacy

ASGCT Holds Third Annual FDA Liaison Meeting

ASGCT Staff - November 24, 2020
Policy & Advocacy

Policy Summit’s Sickle Cell Disease Session Emphasizes Patient Access

Emily Nettesheim - October 05, 2020